1. Ala–Houhala M, Korpela R, Koivikko M, Koskinen T, Koskinen M, Koivula T (1986) Long–term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children. Neuropediatrics 17:212–216
2. Burt R, Freston JW, Tolman KG (1976) The influence of phenobarbital on biotransformation of 25–hydroxycalciferol. J Clin Pharmacol 16(8–9):393–398
3. Collins N, Maher J, Cole M, Baker M, Callaghan N (1991) A prospective study to evaluate the dose of vitamin D required to correct low 25–hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug–induced osteomalacia. QJ Med 78(286):113–122
4. Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA (2000) Long–term anticonvulsant therapy leads to low bone mineral density – evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast–like cells. Exp Clin Endocrinol Diabetes 108(1):37–43
5. Gascon–Barre M, Cote MB (1978) Influence of phenobarbital and diphenylhydantoin on the healing of rickets in the rat. Calcif Tissue Res 25(1):93–97